Physician Starting Pay Hits $400,000 A Year https://t.co/DnSSH4mGGX https://t.co/XMZVgZlVIZ ...

Financial Performance Highlights - Swire Pacific's underlying profit decreased by 2% to HK$5476 million in 1H2025, compared to HK$5576 million in 1H2024 [24, 34] - Recurring underlying profit decreased slightly by 1% to HK$4712 million in 1H2025 from HK$4762 million in 1H2024 [24, 34] - Ordinary dividend per 'A' share increased by 4% to HK$130 [24, 31, 34] - Revenue increased by 16% to HK$45774 million in 1H2025 from HK$39563 million in 1H2024 [34] Business Segment Performance - Property division's underlying profit increased by 15% to HK$4406 million [56] - Beverages division's attributable profit decreased by 9% to HK$803 million [89] - Aviation division (Cathay group) attributable profit increased by 1% to HK$1642 million [38, 98] - HAECO group recurring profit increased significantly by 40% to HK$561 million [30, 98, 118] Property Investment and Development - 67% committed in HK$100 billion investment plan [22, 58] - Completed the sale of interests in Brickell City Centre retail and parking spaces, as well as the adjacent sites, in Miami, USA [22] - Chinese Mainland portfolio contributed 42% attributable gross rental income in 1H2025 [71, 73] Beverages - Swire Coca-Cola - Revenue increased by 25% to HK$22188 million [89] - EBITDA margin remained almost flat at 128% [89, 91] - Inaugurated a new US$136 million flagship plant in Tay Ninh, Vietnam [78] Aviation - Cathay Pacific and HAECO - Cathay group reported a group profit of HK$43 billion [101] - HAECO group achieved a 40% growth in recurring profit [30, 98, 118]

Core Viewpoint - NextPlat Corp is set to release its financial results for the quarter ended June 30, 2025, on August 14, 2025, before market open, and will host a conference call to discuss these results and recent developments [1][2]. Group 1: Financial Results Announcement - NextPlat Corp will announce its financial results for Q2 2025 on August 14, 2025, before the market opens [1]. - The conference call will be hosted by Interim CEO David Phipps and CFO Cecile Munnik at 8:30 a.m. EDT [2]. Group 2: Conference Call Details - Investors can submit questions for the Q&A portion of the call before August 12, 2025 [2]. - The call can be accessed via a toll-free number (1-800-836-8184) or an international number (1-646-357-8785) [2]. - A live broadcast and replay of the conference call will be available on the company's website [3]. Group 3: Company Overview - NextPlat is a global consumer products and services company that provides healthcare and technology solutions through eCommerce and retail channels [4]. - The company aims to assist businesses in optimizing their eCommerce presence and revenue through acquisitions, joint ventures, and collaborations [4]. - NextPlat operates an eCommerce communications division and offers pharmacy and healthcare data management services in the U.S. through its subsidiary, Progressive Care [4].

Physician Starting Pay Hits $400,000 A Year https://t.co/UpMlwgtaxb https://t.co/t1K2fIfxl4 ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased common stock of Hims & Hers Health, Inc. during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1][2]. Group 1: Class Action Details - The Class Period for the lawsuit is from April 29, 2025, to June 23, 2025, and the lead plaintiff deadline is August 25, 2025 [1]. - Investors who purchased Hims common stock during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. Group 2: Legal Representation - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [3]. - The firm has achieved significant settlements in the past, including the largest securities class action settlement against a Chinese company at the time and has recovered hundreds of millions of dollars for investors [3]. Group 3: Case Allegations - The lawsuit alleges that Hims made false and misleading statements regarding its partnership with Novo Nordisk A/S, which affected investors' decisions [4]. - Specific claims include the failure to disclose the nature of the collaboration with Novo and the implications for Hims subscribers' access to the weight-loss drug Wegovy [4].

Physician Starting Pay Hits $400,000 A Year https://t.co/0E1WCzh3bW https://t.co/jMWEgJZNvm ...

Financial Data and Key Metrics Changes - Second quarter sales reached $3.3 billion, growing 2% on an organic basis [6][15] - Operating EBITDA was $859 million, an increase of 8% year over year, resulting in an operating EBITDA margin of 26.4%, up 120 basis points from the prior year [6][17] - Adjusted EPS for the quarter was $1.12, up 15% year over year [6][19] Business Line Data and Key Metrics Changes - Electronics Co. net sales were $1.2 billion, up 6% year over year, driven by an 8% increase in volume [20] - Industrials Co. second quarter net sales were $2.1 billion, up 1% year over year, with 2% volume growth partially offset by a 1% decline in price [21][22] - Healthcare and Water Technologies saw high single-digit organic sales growth, while diversified industrial sales were down low single digits due to construction market softness [22][46] Market Data and Key Metrics Changes - Asia Pacific delivered 4% organic sales growth year over year, with Europe up 2% and North America up 1% [16] - The electronics market remains mixed, with growth primarily driven by AI applications, while consumer markets are still relatively weak [56][57] Company Strategy and Development Direction - The company is focused on the upcoming spin-off of Qunity Electronics, scheduled for November 1, aiming to position both entities for growth [8][10] - The new DuPont will emphasize high-growth healthcare and water markets, with plans for potential acquisitions to bolster these segments [12][71] - The company is committed to maintaining a strong cash flow and operational efficiency while navigating the separation process [8][24] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about continued strength in electronics driven by AI technology demand, while acknowledging ongoing weakness in the construction sector [7][24] - The company raised its full-year earnings guidance based on strong second-quarter performance, despite anticipated tariff impacts [23][24] - Management highlighted the importance of customer relationships and market positioning in driving future growth [71] Other Important Information - A settlement with the State of New Jersey regarding environmental claims was announced, with the company's portion amounting to $177 million on an NPV basis [8][41] - The company is actively pursuing M&A opportunities to enhance its healthcare and water portfolios [72] Q&A Session Summary Question: Insights on industrials and pricing impacts - Management clarified that the 1% price decline was primarily due to price adjustments following inflationary pressures, not specific to the healthcare or tieback sectors [30][31] Question: Comments on the recent settlement - Management expressed satisfaction with the settlement, noting that AFFF claims represented only 1% of the total settlement amount, aligning with previous estimates [39][41] Question: Growth in healthcare and water sectors - Both healthcare and water sectors experienced high single-digit growth, with expectations for continued outsized growth in the back half of the year [46][47] Question: Electronics market trends - Management noted that growth is primarily driven by AI applications, with expectations for gradual recovery in the broader electronics market [56][57] Question: Future M&A strategies - The focus remains on completing the spin-off of Qunity, while actively scouting for M&A opportunities in the healthcare and water sectors [72][73] Question: Tariff impacts and mitigation strategies - Over 90% of the tariff impact mitigation is attributed to supply chain movements, with some surcharges implemented to offset costs [132][133]

NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate. WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our ...

Core Viewpoint - Auddia Inc. is restructuring into a holding company focused on leveraging AI and web3 efficiencies to enhance its portfolio companies, with a proposed business combination with Thramann Holdings, LLC [1][3]. Group 1: Business Combination Details - Auddia's Board has approved a non-binding letter of intent for a business combination with Thramann Holdings, which controls three early-stage AI-native companies [1][2]. - The proposed terms indicate that Holdings' equity holders will receive an 80% ownership interest in the combined company, while Auddia equity holders will own 20% [4]. - The business combination is a related party transaction, with Jeff Thramann being the founder and majority shareholder of Holdings [6]. Group 2: Leadership and Management - Following the business combination, Auddia's current board will initially oversee the new holding company, with Jeff Thramann continuing as CEO and John Mahoney as CFO [5]. - Auddia's leadership has formed a Special Committee of Independent Directors to address potential conflicts of interest related to the transaction [6]. Group 3: Financial and Operational Conditions - The closing of the business combination is contingent upon Auddia raising at least $10 million in additional capital to support ongoing operations [7]. - The parties have agreed to a 30-day exclusivity period to negotiate a definitive business combination agreement, which will include customary closing conditions [7]. Group 4: Portfolio Companies - Thramann Holdings controls LT350, Influence Healthcare, and Voyex, which are focused on AI applications in various sectors [2][10]. - LT350 has developed a solar parking lot canopy that can transform parking lots into distributed AI data centers, while Influence Healthcare leverages AI and blockchain for value-based care [11][12].

Investment Rating - The report suggests a selective participation strategy in sectors with attractive risk-reward profiles, specifically highlighting solar, chemicals, and lithium as top picks [1][6]. Core Insights - The anti-involution campaign is broadening into various sectors, including healthcare and financial services, with mixed feedback from analysts regarding its potential impact [1][2]. - Despite skepticism in the market about the effectiveness of the anti-involution initiatives, the motivations behind these initiatives are considered valid, leading to an upside skew in share price risks [3]. - The report emphasizes that the relevant sectors have not significantly outperformed the broader market, and investor expectations are generally low, indicating potential for positive surprises in future policies [3]. Sector Summaries Solar - The solar sector is characterized by very low profitability compared to other sectors, with significant long-term growth potential and external pressures to reduce excess capacity [6][8]. Chemicals - The chemicals sector faces low profitability and is close to historical troughs in valuation, with potential for cutting outdated capacities [6][8]. Lithium - The lithium sector is noted for its strong long-term growth potential and asymmetric risk-return profile, making it an attractive investment opportunity [6][8]. Auto - The auto sector is under pressure from fierce price competition and global excess capacity, with regulatory scrutiny aimed at promoting rational competition [2][8]. Healthcare - In healthcare, the focus is shifting towards non-price conditions in procurement, which may impact pricing strategies in the sector [2][8]. Food Delivery - The food delivery sector is experiencing regulatory pressure to rectify aggressive promotional practices, which may affect demand sensitivity [2][8]. Coal - The coal sector is facing production limits in certain provinces, which could lead to slight price increases [2][8]. Hog - The hog sector is under scrutiny for production capacity controls, with recent upward revisions in price forecasts [2][8].